MIFH
Migdal Insurance & Financial Holdings Portfolio holdings
AUM
$8.42B
1-Year Return
18.65%
This Quarter Return
+9.69%
1 Year Return
+18.65%
3 Year Return
+96.52%
5 Year Return
+186.2%
10 Year Return
–
AUM
$9.92B
AUM Growth
+$1.45B
(+17%)
Cap. Flow
+$1.11B
Cap. Flow
% of AUM
11.16%
Top 10 Holdings %
Top 10 Hldgs %
34.07%
Holding
759
New
112
Increased
319
Reduced
155
Closed
92
Top Buys
| 1 |
Vanguard Russell 2000 ETF
VTWO
|
+$632M |
| 2 |
SPDR S&P Bank ETF
KBE
|
+$112M |
| 3 |
iShares US Transportation ETF
IYT
|
+$94M |
| 4 |
iShares Cybersecurity and Tech ETF
IHAK
|
+$69.8M |
| 5 |
Deere & Co
DE
|
+$69.4M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$553M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$101M |
| 3 |
VanEck Semiconductor ETF
SMH
|
+$96.4M |
| 4 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$93.6M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$73.8M |
Sector Composition
| 1 | Technology | 19.49% |
| 2 | Consumer Discretionary | 11.82% |
| 3 | Financials | 9.71% |
| 4 | Communication Services | 6.93% |
| 5 | Industrials | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Gilead Sciences
GILD
$142B
| $598K | 0.01% |
9,257
+8,039
| +660% | +$519K |
|
302
Ionis Pharmaceuticals
IONS
$10.1B
| $598K | 0.01% |
13,305
+8,257
| +164% | +$371K |
|
303
Personalis
PSNL
$519M
| $579K | 0.01% |
23,514
+14,592
| +164% | +$359K |
|
304
Parsons
PSN
$8.18B
| $578K | 0.01% |
14,290
+1,208
| +9% | +$48.9K |
|
305
Adaptive Biotechnologies
ADPT
$1.92B
| $570K | 0.01% |
14,169
+8,793
| +164% | +$354K |
|
|
LFC
306
DELISTED
China Life Insurance Company Ltd.
LFC
| $567K | 0.01% |
54,508
+1,750
| +3% | +$18.2K |
|
307
Moderna
MRNA
$9.15B
| $565K | 0.01% |
4,312
+2,676
| +164% | +$351K |
|
308
Trip.com Group
TCOM
$48.3B
| $552K | 0.01% |
13,933
+4,164
| +43% | +$165K |
|
309
Precigen
PGEN
$1.13B
| $551K | 0.01% |
80,016
+49,656
| +164% | +$342K |
|
310
Infosys
INFY
$70.3B
| $543K | 0.01% |
29,016
+2,000
| +7% | +$37.4K |
|
311
Coca-Cola
KO
$288B
| $543K | 0.01% |
10,305
+9,300
| +925% | +$490K |
|
|
MANT
312
DELISTED
Mantech International Corp
MANT
| $529K | 0.01% |
6,080
+516
| +9% | +$44.9K |
|
313
Invesco QQQ Trust
QQQ
$373B
| $523K | 0.01% |
1,640
+100
| +6% | +$31.9K |
|
|
RTL
314
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $521K | 0.01% |
+53,062
| New | +$521K |
|
|
NVTA
315
DELISTED
Invitae Corporation
NVTA
| $518K | 0.01% |
13,544
+8,405
| +164% | +$321K |
|
316
Invesco Fundamental High Yield Corporate Bond ETF
PHB
$355M
| $514K | 0.01% |
26,569
-2,242
| -8% | -$43.4K |
|
|
TBIO
317
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $509K | 0.01% |
30,852
+19,146
| +164% | +$316K |
|
318
Black Diamond Therapeutics
BDTX
$185M
| $504K | 0.01% |
20,770
+12,889
| +164% | +$313K |
|
319
Inovio Pharmaceuticals
INO
$126M
| $503K | 0.01% |
4,514
+2,801
| +164% | +$312K |
|
320
Standard BioTools
LAB
$493M
| $501K | 0.01% |
110,807
+68,764
| +164% | +$311K |
|
321
PTC Therapeutics
PTCT
$4.85B
| $501K | 0.01% |
10,571
+6,560
| +164% | +$311K |
|
322
Passage Bio
PASG
$22.3M
| $494K | 0.01% |
1,413
+877
| +164% | +$307K |
|
|
TWOU
323
DELISTED
2U, Inc.
TWOU
| $492K | 0.01% |
429
+150
| +54% | +$172K |
|
324
Ciena
CIEN
$18.6B
| $487K | ﹤0.01% |
8,899
+3,841
| +76% | +$210K |
|
325
Teladoc Health
TDOC
$1.36B
| $477K | ﹤0.01% |
+2,625
| New | +$477K |
|